Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • July 2004 | Volume 17 - Issue 7

    3,592 reads | 0 comments | 07/03/04
    When treating diabetic patients who have neuropathic ulcers, it can be challenging to apply a wound care ointment with a wooden applicator or cotton swab due to pain tolerance issues. However, a new spray version of Panafil® may be able to address these concerns. Healthpoint, the manufacturer of Panafil Spray, says the spray is light so it doesn’t hurt a sensitive wound bed and facilitates easier access with tough to reach areas of irregularly-shaped wounds. The company also emphasizes that using the spray minimizes the potential for cross-contamination, a significant benefi ... continue reading
    By Jeff Hall, Editor-in-Chief
    2,291 reads | 0 comments | 07/03/04
    Consider the dizzying array of choices one must make when a patient presents with a non-healing wound. In some cases, determining the etiology can be a daunting challenge. In their guest column for Diabetes Watch, Damieon Brown, DPM, and Javier La Fontaine, DPM, discuss the difficulties of detecting diabetic autonomic neuropathy and provide an illuminating case study that reflects the subsequent challenges of treating these patients for chronic wounds (see page 20). Within this month’s continuing education article, “How To Detect And Treat Infected Wounds” (see page 68), John S. Stei ... continue reading
    By Brian McCurdy, Associate Editor
    9,643 reads | 0 comments | 07/03/04
    Painful foot neuromas are a common dilemma among podiatric patients and the neuromas appear to be increasingly more prevalent among runners. Samuel Nava, Jr., DPM, a Fellow of the American College of Foot and Ankle Surgeons (ACFAS), estimates that approximately 10 to 15 percent of his patients with neuromas are female runners. He notes that female runners who wear more narrow shoes at work and subsequently go running on hard surfaces may be at a higher risk for developing neuromas. Bruce Werber, DPM, a Fellow and Past President of ACFAS, says the majority of his neuroma patients are female bu ... continue reading
    By Lynnelle R. Gabriel, DPM
    37,873 reads | 0 comments | 07/03/04
    Treating a Morton’s neuroma can be a delicate operation. There is currently much discussion and controversy over whether to remove an intermetatarsal neuroma or leave the nerve intact and release the deep transverse intermetatarsal ligament via a minimally invasive nerve decompression (MIND). There have not been enough studies to sway the majority of surgeons to leave the intermetatarsal neuroma and only release the ligament. Although I believe this is truly an entrapment of the nerve, I have found removing the neuroma has been quite successful. The clinical signs and symptoms of a neurom ... continue reading